DKSH Thailand delivers more than 70 million doses of COVID-19 vaccine to Thai people
text size

DKSH Thailand delivers more than 70 million doses of COVID-19 vaccine to Thai people

DKSH has been at the forefront of supporting Thailand’s COVID-19 vaccine rollout since the country’s very first vaccine shipment arrived in February of 2021.

DKSH Business Unit Healthcare was instrumental in ensuring the inoculation of Thais across the kingdom. On 9 March, the company celebrated its milestone of delivering over 70 million doses of the COVID-19 vaccines on behalf of the Thai government and various partners. An essential driving force in the fight against COVID-19, DKSH has delivered vaccines from various manufacturers to hospitals nationwide.

This milestone was made possible through DKSH’s extensive healthcare infrastructure and capillary distribution networks, built by a workforce of over 3,000 specialists who worked tirelessly to ensure the COVID-19 vaccines were delivered in a reliable and efficient manner. Thanks to its cold chain excellence and unique Vaccine Solutions Management system which encompasses everything from warehousing to point of care management, DKSH has the capabilities and expertise to manage the storage and distribution of COVID-19 vaccines, cold chain products, medicines, and medical devices for local and international healthcare businesses. The company is proud to be a part of this rapid inoculation scale up at the national level which has improved the wellbeing of many patients and healthcare professionals, reflecting DKSH’s core purpose in enriching people’s lives. 

John Clare, Vice President, Business Unit Healthcare, DKSH Thailand and Indochina, commented: “DKSH has set the pace for COVID-19 vaccine delivery and is leading the way towards the future of healthcare whereby state-of-the-art cold chain solutions would become increasingly important. As one of Asia’s biggest Healthcare service providers, we are committed to using our extensive capabilities to continue driving equitable access to the vaccines and contribute towards safeguarding public health and safety.”

Do you like the content of this article?
COMMENT (2)